ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Funds

Funds (GSLF)

30.97
0.13
(0.42%)
Closed December 05 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
30.97
Bid
0.00
Ask
0.00
Volume
5,384
30.97 Day's Range 30.97
28.59 52 Week Range 30.97
Previous Close
30.84
Open
30.97
Last Trade
5162
@
30.97
Last Trade Time
Average Volume (3m)
2,813
Financial Volume
-
VWAP
-

GSLF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.411.3416230366530.5630.9730.56397730.72044252DE
40.862.856193955530.1130.9730.11341530.47046386DE
120.642.1101219914330.3330.9729.83281330.40470753DE
260.732.4140211640230.2430.9729.33416830.11384007DE
522.388.3245890171428.5930.9728.59375329.9342728DE
1562.187.5720736366828.7930.9726.71458128.87982495DE
2602.187.5720736366828.7930.9726.71458128.87982495DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALNEVNeovacs
3.00 €
(999,900.00%)
2.63k
BNBSTonner Drones
0.001 €
(100.00%)
210
ALLPLLepermislibre SA
0.544 €
(74.92%)
19.4k
GJAJGroupe Jaj
0.85 €
(41.67%)
6
ECTEurocastle Investment
7.50 €
(38.89%)
1.63k
MLWEYWeya
0.0155 €
(-57.53%)
10.65k
ATOAtos SE
0.1778 €
(-47.55%)
22.16M
CLEXCumulex NV
0.81 €
(-40.00%)
925
ALSAFSAFE
0.066 €
(-23.26%)
676.48k
ALSPWSpineway
0.1012 €
(-16.98%)
2.9M
BCPBanco Comercial Portugues SA
0.4531 €
(1.39%)
72.44M
ALCYBCybergun
0.0001 €
(0.00%)
48.54M
ATOAtos SE
0.1778 €
(-47.55%)
22.16M
ALVERVergnet
0.0032 €
(6.67%)
19.31M
ALHPIHopium SA
0.0083 €
(-6.74%)
17.29M

Discussion

View Full Feed
band aid band aid 3 minutes ago
Does anyone think they will figure out how to sell a few more trinkets then they have in the past. I guess we shall see in the once a year financial reports. Then maybe the company may have a couple of bucks in the bank.
BIEL
northam43 northam43 3 minutes ago
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
zab zab 4 minutes ago
The trump clown show is in full display for everyone to see, another reason only 49 percent of America voted for orange shittypants.  But remember trump will blame everyone else for his daily mistakes,  and meltdowns.
MartinLutherKing MartinLutherKing 4 minutes ago
5.TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology compan
RNAZ
misterfishman misterfishman 4 minutes ago
There is plenty of frustration going on over here mostly due to impatience peeps this stock is a longterm play like a few years out if peeps can't wait then sell.its that simple.
IGPK
bananarama bananarama 4 minutes ago
I totally agree with you, Monkey! Any company interested in buying KBLB would recognize that it is better to buy the company now rather than wait for it to reach the Texas Exchange (or the NASDQ). Then, the BO price will be MUCH MUCH higher. GO KBLB! ;-)
KBLB
MartinLutherKing MartinLutherKing 5 minutes ago
4.TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today an
RNAZ
Richard H2 Richard H2 5 minutes ago
Just in:

http://www.nashvillechanceryinfo.org/CaseDetail.aspx?CaseID=80738

IN THE CHANCERY COURT FOR THE STATE OF TENNESSEE
TWENTIETH JUDICIAL DISTRICT, DAVIDSON COUNTY – CASE No.23-1020-II

B&K ENERGY, LLC – Plaintiff
v
HOLCOMB ENE
BKH
Dr Quest Dr Quest 6 minutes ago
"Existing management has already for two years overstated the value of the Company by advancing the ~$10.00 per share NAV narrative. "

So with the current offer by Ready, the merger price comes in at 5.50+/share. That would be a erosion of value of 45% over two years. Over those same
MartinLutherKing MartinLutherKing 6 minutes ago
3.TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
August 15 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced initiation of its Pha
RNAZ
Gamco Gamco 7 minutes ago
style="font-size: 16px"From Gemini:
style="font-size: 16px"

style="font-size: 16px"The potential implications of Tesla's appeal for a UK global FRAND rate ruling against Avanci/InterDigital are significant and could reshape the landscape of patent licensing in the t
IDCC
Zorch305 Zorch305 7 minutes ago
Lots of goodluck with Multiple irons in the fire!!
RDAR
Dragonman1 Dragonman1 8 minutes ago
I never said I was looking at this Co For a pump and dump your a liar!
KEGS
northam43 northam43 8 minutes ago
Report #6 SPX All Cycles Chart.

https://investorshub.advfn.com/uimage/uploads/2024/12/5/kxaxx6_All_Cycles_Chart.png
MartinLutherKing MartinLutherKing 8 minutes ago
2. TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
May 29 2024 - 9:15AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer
RNAZ
No-Quarter No-Quarter 8 minutes ago
That's a new one for me. Added. Thx
PickStocks PickStocks 9 minutes ago
Quote: " style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: Nunito, serif; background-color: rgba(255, 255, 255, 1); font-size: 1em"Chad and Doreen can’t tell you, I, or AZ anything."
style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-fami
COOP
nowwhat2 nowwhat2 9 minutes ago
Oh no......Not again !

https://investorshub.advfn.com/uimage/uploads/2024/12/5/vxyosxrp_121212_5_hyper_CAPT_not_again.jpg



FOMO
XRPUSD
arizona1 arizona1 9 minutes ago
I absolutely can understand why the UHC president was murdered.

I don’t like that it happened, but I can understand why people would want him dead, given the reports of UHC denying coverage to patients, which in this day and age, can mean that those patients die for lack of treatment.
MartinLutherKing MartinLutherKing 9 minutes ago
1. TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15 2024 - 9:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cance
RNAZ
fwb fwb 11 minutes ago
NVDA will SUPPLY the HARDWARE (CHIPS)
The computers will be built by others.
PLTR will be one of the SOFTWARE Companies those Computers will run on that will help the companies using them to improve on efficiency
It's how all these companies will USE these products for their bus
NVDA PLTR
BeepBeepMF BeepBeepMF 12 minutes ago
that chart ❤️ what a beaut it is $RDAR
RDAR